Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 20/20 | 0.82 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27792386 | 0.94 | MAPK14 (0.84) | MAPK14 | |
| SCHEMBL435937 | 0.92 | MAPK14 (0.82) | MAPK14 | |
| SCHEMBL451047 | 0.92 | MAPK14 (0.85) | MAPK14RPS6KA5CYP3A4MAPKAPK2KCNH2 | |
| SCHEMBL449661 | 0.91 | MAPK14 (0.84) | MAPK14RPS6KA5CYP3A4MAPKAPK2KCNH2 | |
| SCHEMBL449753 | 0.91 | MAPK14 (1.00) | MAPK14 | |
| SCHEMBL436871 | 0.88 | MAPK14 (0.83) | MAPK14 | |
| SCHEMBL27792333 | 0.87 | MAPK14 (0.78) | MAPK14RPS6KA5CYP3A4MAPKAPK2KCNH2 | |
| SCHEMBL448530 | 0.87 | MAPK14 (0.86) | MAPK14 | |
| SCHEMBL447744 | 0.86 | MAPK14 (0.85) | MAPK14 | |
| SCHEMBL451149 | 0.85 | MAPK14 (0.90) | MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101842361-B | Pyrazinone derivatives and their use in the treatment of lung diseases | ASTRAZENECA AB | 2013-06-05 | — | — | CN | disclosed |
| CN-101842361-A | Pyrazinone derivatives and their use in the treatment of lung diseases | ASTRAZENECA AB | 2010-09-22 | — | — | CN | disclosed |